Three companies from sub-Saharan Africa, including Aspen Pharmacare Holdings ( APNHF) ( APNHY ), and four from India, ...

Canonsburg, Pennsylvania-based Viatris Inc. (VTRS) is a global healthcare company that develops, manufactures, and markets ...

In the latest pair of Untitled Letters, the FDA took issue with a Viatris TV ad and Sanofi’s promotional emails.

VR-205 reduced UPCR by 33.75% at nine months compared to baseline.

Viatris Inc. (NASDAQ:VTRS) is one of the 10 Most Undervalued NASDAQ Stocks to Buy Right Now. On June 29, Viatris announced positive top-line results from a Phase 3 clinical trial of VR-205 ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping t ...

Viatris routinely posts information that may be important to investors on our website at investor.viatris.com, and we use this website address as a means of disclosing material information to the ...

The transaction accelerates the expiration of biosimilars non-compete restrictions, the company said. The shares are subject to a six-month lock up period. Transaction value will be subject to related ...

Viatris recently launched Unmind as part of its global well-being program, Elevate. Unmind is a provider of workplace mental health solutions designed by psychologists to help individuals understand ...

Viatris has agreed to a settlement in which it will pay up to $335 million to resolve opioid-related claims to state and local governments, the Pittsburgh-based generics specialist said on Monday.

NCDs are the leading cause of death globally, representing a significant burden to people and health care systems. As many as 18 million people die annually before the age of 70 from NCDs including ...